Earnings Ahead

PFE - Pfizer

29.47 0.38 1.31

Pfizer

Pfizer

About

Profile

Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.


Headquarters

New York City, New York, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

PFE

Shares rose slightly after the pharmaceutical giant said Tuesday that its respiratory syncytial virus vaccine showed potential to protect adults under 60 years old from of getting severely sick.


 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Pfizer reports 54% contraction in Q2 sales amid COVID cliff
  • Pfizer reports mixed Q2 earnings; narrows FY23 outlook
  • Pfizer seen reporting sharply lower Q2 sales as COVID-19 vaccine demand wanes
  • RSV treatment market to surge past $9B by 2029
  • Catalyst Watch: Amazon earnings, jobs report, and will Apple talk AI?
  • AstraZeneca unit in $1B deal with Pfizer for gene therapies
  • Pfizer restructuring leadership in R&D
  • Merck pneumococcal vaccine outperforms PCV20 in Phase 3 trials
  • GSK announces EU nod for HIV prevention therapy
  • Syros falls as Pfizer ends collaboration
  • Pfizer, Gilead, GSK set to dominate infectious diseases market
  • Pfizer wins EU backing for RSV vaccine
  • Dividend Roundup: Bank of America, Ford, Pfizer, Kinder Morgan, and more
  • Morgan Stanley sees tornado-ravaged plant's impact on Pfizer as minimal
  • Lawmakers reintroduce bill to offer Medicare coverage for weight loss drugs
  • Pfizer says phase 2 data shows efficacy of maternal strep vaccine
  • Pfizer plant in NC severely damaged by strong tornado
  • Pfizer, venture capital company to work on drugs for unmet needs
  • HSBC bullish on Roche, Lonza; bearish on Bristol-Myers, GSK, Moderna
  • Eli Lilly, Merck among top pharma picks in Barclays Q2 preview

Earnings History

Date EPS / Forecast Revenue / Forecast
February 8, 2022 1.08 / 0.8742 23.84B / 24.16B
November 2, 2021 1.34 / 1.08 24.09B / 22.58B Beat!
July 28, 2021 1.07 / 0.9705 18.98B / 18.71B Beat!
May 4, 2021 0.93 / 0.7759 14.58B / 13.65B Beat!
February 2, 2021 0.42 / 0.4952 11.68B / 11.47B Beat!
October 27, 2020 0.72 / 0.7139 12.13B / 12.31B
August 4, 2020 - / 0.68 - / 11.67B
April 28, 2020 0.8 / 0.73 12.03B / 11.81B Beat!
January 28, 2020 0.55 / 0.58 12.69B / 12.61B Beat!
October 29, 2019 0.75 / 0.62 12.68B / 12.26B Beat!
July 29, 2019 0.8 / 0.75 13.26B / 13.4B
April 30, 2019 0.85 / 0.75 13.12B / 12.99B Beat!
January 29, 2019 0.64 / 0.63 13.98B / 13.9B Beat!
October 30, 2018 0.78 / 0.75 13.3B / 13.5B
July 31, 2018 0.81 / 0.74 13.47B / 13.31B Beat!
May 1, 2018 0.77 / 0.74 12.91B / 13.14B
January 30, 2018 0.62 / 0.56 13.70B / 13,684M
October 31, 2017 0.67 / 0.64 12.90B / 13,175M
August 1, 2017 0.67 / 0.66 12.78B / 13,081M
May 2, 2017 0.69 / 0.67 12.78B / 13,080M
Date Price Open High Low Vol Change ER
May 26, 2023 37.6 38.04
38.44
37.56
19.6M -0.61%
May 25, 2023 37.83 38.51
38.51
37.65
29.2M -2.07%
May 24, 2023 38.63 40.1
40.14
38.6
38.9M -2.55%
May 23, 2023 39.64 38.55
40.14
38
74.5M 2.30%
May 22, 2023 38.75 36.86
38.87
36.75
84.7M 5.38%
 
May 19, 2023 36.77 36.65
37.65
36.52
33.1M 0.79%
May 18, 2023 36.48 36.71
36.78
36.17
27.3M -0.73%
May 17, 2023 36.75 36.98
37.05
36.51
23.2M -0.7%
May 16, 2023 37.01 37.02
37.24
36.83
25.5M -0.4%
May 15, 2023 37.16 37.3
37.36
37.01
16.7M -0.51%
May 12, 2023 37.35 37.61
37.72
37.23
16.5M -0.61%
May 11, 2023 37.58 37.6
37.65
37.21
28.6M -1.88%
May 10, 2023 38.3 38.67
38.72
38.08
15.9M -0.47%
May 9, 2023 38.48 38.48
38.67
38.39
16.0M -0.49%
May 8, 2023 38.67 38.53
38.73
38.35
20.1M 0.47%
May 5, 2023 38.49 38.38
38.5
38.09
19.2M 0.68%
May 4, 2023 38.23 38.17
38.43
38.02
23.7M -0.57%
May 3, 2023 38.45 39.2
39.39
38.36
27.7M -1.56%
May 2, 2023 39.06 39.29
40.12
38.63
38.8M -0.38%
May 1, 2023 39.21 39
39.52
38.86
23.9M 0.82%
Apr 28, 2023 38.89 38.7
38.91
38.62
21.0M 0.39%
Apr 27, 2023 38.74 38.62
38.83
38.31
22.4M 0.28%
Apr 26, 2023 38.63 39.16
39.19
38.4
22.4M -1.78%
Apr 25, 2023 39.33 39.75
39.92
39.28
24.5M -1.45%
Apr 24, 2023 39.91 40.19
40.2
39.71
17.6M -0.75%
Apr 21, 2023 40.21 40.09
40.3
39.9
19.2M 0.90%
Apr 20, 2023 39.85 40.08
40.19
39.79
20.1M -0.97%
Apr 19, 2023 40.24 40.43
40.56
40.2
17.2M -0.76%
Apr 18, 2023 40.55 41.28
41.33
40.53
18.5M -1.53%
Apr 17, 2023 41.18 41.12
41.28
40.96
17.6M -0.02%
Apr 14, 2023 41.19 41.51
41.71
40.93
20.6M -0.68%
Apr 13, 2023 41.47 41.53
41.7
41.29
22.9M 0.24%
Apr 12, 2023 41.37 41.63
41.79
41.27
17.0M -1.01%
Apr 11, 2023 41.79 41.8
41.99
41.7
15.3M 0.14%
Apr 10, 2023 41.73 41.15
41.74
41.12
15.1M 0.55%
Apr 6, 2023 41.5 41.93
42.1
41.37
25.9M -0.12%
Apr 5, 2023 41.55 41.28
42.22
41.17
29.7M 1.59%
Apr 4, 2023 40.9 41.44
41.53
40.76
19.5M -1.09%
Apr 3, 2023 41.35 40.69
41.47
40.65
20.8M 1.35%
Mar 31, 2023 40.8 40.55
40.83
40.28
23.4M 1.04%
Mar 30, 2023 40.38 40.42
40.49
40.25
12.6M 0.32%
Mar 29, 2023 40.25 40.16
40.27
39.99
14.4M 0.65%
Mar 28, 2023 39.99 40.2
40.3
39.86
13.5M -0.57%
Mar 27, 2023 40.22 40.54
40.62
39.97
20.3M -0.42%
Mar 24, 2023 40.39 40.09
40.46
39.87
17.2M 0.52%
Mar 23, 2023 40.18 40.17
40.5
40
17.0M 0.42%
Mar 22, 2023 40.01 40.7
40.85
39.99
15.4M -1.6%
Mar 21, 2023 40.66 40.86
40.91
40.31
20.0M -0.37%
Mar 20, 2023 40.81 40.14
40.86
39.94
20.8M 1.77%
Mar 17, 2023 40.1 40.63
40.79
39.99
57.5M -0.67%
Mar 16, 2023 40.37 40.06
40.49
39.72
21.1M 0.22%
Mar 15, 2023 40.28 39.76
40.53
39.46
25.5M 0.95%
Mar 14, 2023 39.9 40.05
40.15
39.52
24.6M 0.10%
Mar 13, 2023 39.86 39.26
40.51
39.26
35.3M 1.19%
Mar 10, 2023 39.39 39.29
39.93
39.23
26.3M -0.18%
Mar 9, 2023 39.46 40.41
40.57
39.31
18.6M -1.65%
Mar 8, 2023 40.12 40.32
40.57
39.9
16.8M -0.55%
Mar 7, 2023 40.34 41.06
41.13
40.1
23.2M -1.87%
Mar 6, 2023 41.11 41.09
41.26
40.82
19.4M -0.1%
Mar 3, 2023 41.15 40.91
41.18
40.74
20.9M 0%